|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
FY2021
12 months to Jan 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| (Income) from discontinued operations, net of income taxes | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for credit losses | |||||
| Stock-based compensation, excluding cash-settled awards | |||||
| Change in fair value of future tranche right | |||||
| Amortization of discount on convertible notes | |||||
| Benefit from deferred income taxes | |||||
| Non-cash losses on derivative financial instruments, net | |||||
| Losses on early retirements of debt | |||||
| Net (gains) losses on divested businesses | |||||
| Other non-cash items, net | |||||
| Changes in operating assets and liabilities, net of effects of business combinations and divestitures: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Contract liabilities | |||||
| Other liabilities | |||||
| Other, net | |||||
| Net cash provided by operating activities — continuing operations | |||||
| Net cash used in operating activities — discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash paid for asset acquisitions and business combinations, including adjustments, net of cash acquired | |||||
| Divestitures, net of cash divested | |||||
| Purchases of property and equipment | |||||
| Purchases of investments | |||||
| Maturities and sales of investments | |||||
| Cash paid for capitalized software development costs | |||||
| Other investing activities | |||||
| Net cash used in investing activities — continuing operations | |||||
| Net cash provided by investing activities — discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of preferred stock and future tranche right, net of issuance costs | |||||
| Proceeds from borrowings | |||||
| Repayments of borrowings and other financing obligations | |||||
| Payments to repurchase convertible notes | |||||
| Settlement of 2014 Notes | |||||
| Payments of equity issuance, debt issuance, and other debt-related costs | |||||
| Distributions paid to noncontrolling interest | |||||
| Purchases of treasury stock and common stock for retirement | |||||
| Preferred stock dividend payments | |||||
| Payment for termination of interest rate swap | |||||
| Net cash transferred to Cognyte Software Ltd. | |||||
| Dividend and other settlements received from Cognyte Software Ltd. | |||||
| Payments of deferred purchase price and contingent consideration for business combinations (financing portion) and other financing activities | |||||
| Net cash (used in) provided by financing activities — continuing operations | |||||
| Net cash used in financing activities — discontinued operations | |||||
| Payments of contingent consideration for business combinations (financing portion) | |||||
| Cash received for contingent consideration for business divestitures (financing portion) and other financing activities | |||||
| Net cash used in financing activities | |||||
| Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents | |||||
| Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents | |||||
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of year | |||||
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of year | |||||
| Cash and cash equivalents | |||||
Loading...